Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019
Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009
Combined CMV prophylaxis reduces short term complications after lung transplantation Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012
Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx) Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment Year: 2003
Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003
TB in the immunocompromised host Source: Eur Respir Mon 2012; 58: 230-241 Year: 2012
Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching Source: Eur Respir J 2005; 26: Suppl. 49, 636s Year: 2005
Strict antifungal prophylaxis reduces the risk of invasive fungal infections after lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 777s Year: 2006
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001
Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010
CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012
Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002
Incidence of viral infections in patients with lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients Source: International Congress 2018 – Moving lung transplantation forward Year: 2018
Human lung transplantation: cytomegaloviral and rhinoviral co-infection is a distinct risk for acute rejection Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009
Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007
Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation Source: Eur Respir J 2007; 30: Suppl. 51, 174s Year: 2007
Pretransplant factors influencing survival in cystic fibrosis (CF) patients after lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006
Prevalence, screening and treatment of latent tuberculosis among oral corticosteroid recipients Source: Eur Respir J 2014; 44: 1373-1375 Year: 2014